Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for ADHD in youngsters and grown-ups . In Canada, its distribution is managed by Health Canada. This resource seeks to present understandable information on its therapeutic applications , adverse reactions , proper dosag